Abstract
Rheumatoid arthritis (RA) is a multi-system disease with high rates of morbidity and mortality. In recent years, there has been increasing focus on the growing rates of cardiovascular disease (CVD) in RA, over and above expected levels allowing for ‘traditional’ risk factors. In this paper the impact of CVD in RA, the relative contributions of traditional risk factors and novel risk factors (including homocysteine, oxidised low-density lipoprotein, high-sensitivity C-reactive protein and leptin), and the need to address cardiovascular risk in the fight against premature death from coronary artery and stroke disease in RA are discussed.
KEY WORDS: C-reactive protein, cardiovascular disease, coronary artery disease, homocysteine, hyperlipidaemia, hypertension, rheumatoid arthritis
Full Text
The Full Text of this article is available as a PDF (327.2 KB).